DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2217006/ahead-of-cardinal-cah-q2-earnings-get-ready-with-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2217006 Jan 29, 2024 - Get a deeper insight into the potential performance of Cardinal (CAH) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. 0

https://www.zacks.com/stock/news/2215003/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2215003 Jan 24, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. 0

https://www.zacks.com/stock/news/2214297/5-low-leverage-stocks-to-buy-on-expectations-of-rate-cuts?cid=CS-ZC-FT-analyst_blog|rw-2214297 Jan 23, 2024 - The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy NSIT, ACA, CAH, PLAB and WING. 0

https://www.zacks.com/stock/news/2210848/illumina-ilmn-shares-down-1-2-post-preliminary-q4-results?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2210848 Jan 16, 2024 - Illumina's (ILMN) fourth-quarter 2023 results are likely to reflect the impacts of the adoption of its new generation of distributed liquid biopsy assay. 0

https://www.zacks.com/stock/news/2210749/are-investors-undervaluing-cardinal-health-cah-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2210749 Jan 16, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://www.zacks.com/stock/news/2209733/3-top-ranked-large-caps-to-buy-for-growth?cid=CS-ZC-FT-video_blog-2209733 Jan 12, 2024 - Large-caps provide many meaningful advantages, including a less volatile approach, dividend payouts, and greater analyst coverage. 0

https://www.zacks.com/stock/news/2208203/cardinal-health-cah-streamlines-operation-with-new-structure?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2208203 Jan 10, 2024 - Cardinal Health's (CAH) new reporting structure is likely to streamline operations, providing better visibility of growth areas. At-home solutions and OptiFreight Logistics are possibly the key value creators. 0

https://www.zacks.com/stock/news/2206785/5-low-leverage-stocks-to-buy-amid-mixed-investor-sentiments?cid=CS-ZC-FT-analyst_blog|rw-2206785 Jan 08, 2024 - The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy LOB, MAR, CAH, FN and WING. 0

https://www.zacks.com/stock/news/2203633/5-impressive-medtech-industry-growth-stocks-to-buy-for-2024?cid=CS-ZC-FT-analyst_blog|investment_ideas-2203633 Dec 29, 2023 - Stocks such as HAE, PEN, EXAS, PODD and CAH are set to garner remarkable growth for investors. 0

https://www.zacks.com/stock/news/2203174/are-medical-stocks-lagging-aurinia-pharmaceuticals-auph-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2203174 Dec 28, 2023 - Here is how Aurinia Pharmaceuticals (AUPH) and Cardinal Health (CAH) have performed compared to their sector so far this year. 0